Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
about
Lysis of colonic epithelial cells by allogeneic mononuclear and lymphokine activated killer cells derived from peripheral blood and intestinal mucosa: evidence against a pathogenic role in inflammatory bowel diseaseThe NKG2D-IL-15 signaling pathway contributes to T-cell mediated pathology in inflammatory myopathiesSarcoma immunotherapy: past approaches and future directions.Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysis.Interleukin-2: Old and New Approaches to Enhance Immune-Therapeutic Efficacy.
P2860
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells
@nl
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@ast
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@en
type
label
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells
@nl
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@ast
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@en
prefLabel
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells
@nl
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@ast
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@en
P2860
P356
P1433
P1476
Immunotherapy for cancer: the use of lymphokine activated killer (LAK) cells.
@en
P2093
Eddleston AL
P2860
P304
P356
10.1136/GUT.28.2.113
P407
P577
1987-02-01T00:00:00Z